UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

20 Nov 2015

CHMP recommends EU approval for UCB’s new drug brivaracetam for people with epilepsy

Read More
17 Nov 2015

Transparency notification of The Capital Group Companies, Inc.

Read More
28 Oct 2015

Strong growth of core medicines – continued growth of the pipeline

Read More
23 Oct 2015

Acquisition of Own Shares (October 23, 2015)

Read More
16 Oct 2015

Acquisition of own shares (October 16, 2015)

Read More
15 Oct 2015

New Exploratory Analysis Showed Romosozumab Increased Estimated Bone Strength More Than Teriparatide

Read More

Stay up-to-date on the latest news and information from UCB